4757
-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Vascular Health and Risk Management
(1,472,243) Views
Editor in Chief Professor Roland Asmar
Editorial: Metabolic syndrome: sign of things to come ||FREE PAPER||Reza Tabrizchi
Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms
Sudesh Vasdev, Vicki Gill, Pawan K Singal
A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours
Philippe Gosse
Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes
John Pullman, Tamara Darsow, Juan P Frias
Angiogenesis in cancer
Naoyo Nishida, Hirohisa Yano, Takashi Nishida, Toshiharu Kamura, Masamichi Kojiro
Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease
Raed Osman, Philippe L L’Allier, Nader Elgharib, Jean-Claude Tardif
Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?
Jonathan R Emberson, Derrick A Bennett
A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels
Clemens von Schacky
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation
Robert Weiss
Insulin detemir in the treatment of type 1 and type 2 diabetes
Jean-Christophe Philips, André Scheen
Metabolic syndrome: the danger signal in atherosclerosis
Patrick Mathieu, Philippe Pibarot, Jean-Pierre Després
Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models
Demosthenes B Panagiotakos, Vassilis Stavrinos
A large scale study of angiotensin II inhibition therapy in an elderly population: the CHANCE study
Roland Asmar, Sophie Nisse-Durgeat
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
